MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) Receives Average Recommendation of “Hold” from Analysts

Shares of MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY) have received an average recommendation of “Hold” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and three have issued a buy rating on the company.

MKKGY has been the subject of a number of recent analyst reports. Berenberg Bank reaffirmed a “hold” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a research report on Tuesday, June 1st. JPMorgan Chase & Co. restated an “overweight” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a report on Thursday, May 13th. Morgan Stanley reiterated an “equal weight” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a report on Monday, March 8th. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of MERCK Kommanditgesellschaft auf Aktien in a report on Monday, May 17th.

MKKGY stock traded up $0.27 during midday trading on Friday, hitting $38.02. The stock had a trading volume of 41,002 shares, compared to its average volume of 61,242. The business has a 50-day moving average price of $35.15. MERCK Kommanditgesellschaft auf Aktien has a 12-month low of $22.36 and a 12-month high of $38.03.

MERCK Kommanditgesellschaft auf Aktien Company Profile

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat oncology, immuno-oncology, neurology, immunology, fertility, and endocrinology, as well as general medicines for diabetes, cardiovascular, thyroid, and other diseases.

Featured Article: Trading Stocks – What are percentage gainers?

Analyst Recommendations for MERCK Kommanditgesellschaft auf Aktien (OTCMKTS:MKKGY)

Receive News & Ratings for MERCK Kommanditgesellschaft auf Aktien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK Kommanditgesellschaft auf Aktien and related companies with MarketBeat.com's FREE daily email newsletter.